1. Inecalcitol for use in the treatment and / or prevention of rickets, osteoporosis, osteomalacia, psoriasis, autoimmune diseases, such as multiple sclerosis or type 1 diabetes, hyperparathyroidism, benign prostatic hyperplasia, any type of cancer or any disease associated with vitamin D, in doses between 1 mg and 100 mg. 2. Inecalcitol for use according to claim 1, wherein the indicated dose of administration is between 1.5 mg and 20 mg. Inecalcitol for use according to any one of claims 1 or 2, which does not simultaneously cause increased calciumemia in treated patients. Inecalcitol for use according to any one of claims 1 or 2, which includes administering the indicated doses of inecalcitol, with a frequency selected from: every three days, every other day (qod), once a day (qd), twice a day (bid) and three times a day (tid) .5. Inecalcitol for use according to any one of claims 1 or 2, the administration being carried out at intervals selected from: every other day, once a day, and twice a day. Inecalcitol for use according to any one of claims 1 or 2, which also includes administering one or more additional active ingredients selected from anti-osteoporosis agents, immunomodulatory agents, anti-inflammatory drugs, anti-psoriasis drugs, anti-hormonal drugs, anti-proliferative drugs, and anti-cancer drugs. Inecalcitol for use according to claim 6, wherein said additional administration (administration) occurs (occurs) simultaneously, separately or sequentially with the administration of insalcitol. Inecalcitol for use according to any one of claims 1 or 2, which is intended for the treatment of cancer, tumors or leukemia. Inekal1. Инекальцитол для применения с целью лечения и/или профилактики рахита, остеопороза, остеомаляции, псориаза, аутоиммунных заболеваний, таких как рассеянный склероз или диабет 1 типа, гиперпаратиреоза, доброкачественной гиперплазии простаты, любого вида рака или любого заболевания, связанного с витамином D, в дозах, составляющих между 1
